Company facts
- Founded
- 2026
- Headquarters
- Switzerland
About
The Wnt pathway drives cancer growth and drug resistance across all major tumors, yet no Wnt drug has been approved as of today. Pharma giants including Novartis spent 30+ years trying. Every program failed because broad Wnt inhibition causes severe toxicity, making drugs too toxic to dose effectively. Wynveris develop…